Unresolved disorder model. using A ATOM 162 CA AILE 19 6.440 3.719 24.527 0.70 10.14 C Unresolved disorder model. using A ATOM 163 CA BILE 19 6.437 3.726 24.514 0.30 10.22 C Unresolved disorder model. using A ATOM 166 CB AILE 19 5.451 4.792 24.063 0.70 10.51 C Unresolved disorder model. using A ATOM 167 CB BILE 19 5.440 4.791 24.022 0.30 10.52 C Unresolved disorder model. using A ATOM 168 CG1AILE 19 4.402 5.133 25.122 0.70 10.73 C Unresolved disorder model. using A ATOM 169 CG1BILE 19 4.305 5.060 25.017 0.30 10.83 C Unresolved disorder model. using A ATOM 170 CG2AILE 19 4.801 4.388 22.749 0.70 11.43 C Unresolved disorder model. using A ATOM 171 CG2BILE 19 4.911 4.444 22.640 0.30 9.64 C Unresolved disorder model. using A ATOM 172 CD1AILE 19 3.415 6.202 24.739 0.70 15.02 C Unresolved disorder model. using A ATOM 173 CD1BILE 19 4.780 5.663 26.324 0.30 12.98 C Unresolved disorder model. using A ATOM 258 CA AASP 31 -9.520 -11.864 32.621 0.50 11.03 C Unresolved disorder model. using A ATOM 259 CA BASP 31 -9.519 -11.863 32.622 0.50 11.08 C Unresolved disorder model. using A ATOM 262 CB AASP 31 -8.407 -11.839 33.659 0.50 13.36 C Unresolved disorder model. using A ATOM 263 CB BASP 31 -8.497 -11.910 33.755 0.50 12.50 C Unresolved disorder model. using A ATOM 264 CG AASP 31 -8.286 -13.094 34.498 0.50 14.16 C Unresolved disorder model. using A ATOM 265 CG BASP 31 -8.742 -13.043 34.741 0.50 12.73 C Unresolved disorder model. using A ATOM 266 OD1AASP 31 -7.874 -14.162 34.008 0.50 15.08 O Unresolved disorder model. using A ATOM 267 OD1BASP 31 -9.895 -13.496 34.904 0.50 11.81 O Unresolved disorder model. using A ATOM 268 OD2AASP 31 -8.596 -12.961 35.706 0.50 16.05 O Unresolved disorder model. using A ATOM 269 OD2BASP 31 -7.764 -13.501 35.394 0.50 13.78 O Unresolved disorder model. using A ATOM 413 CA AGLN 50 -25.775 9.807 9.665 0.50 18.72 C Unresolved disorder model. using A ATOM 414 CA BGLN 50 -25.793 9.764 9.617 0.50 18.72 C Unresolved disorder model. using A ATOM 417 CB AGLN 50 -25.961 11.232 10.230 0.50 21.40 C Unresolved disorder model. using A ATOM 418 CB BGLN 50 -26.026 11.212 10.065 0.50 21.16 C Unresolved disorder model. using A ATOM 419 CG AGLN 50 -27.433 11.560 10.496 0.50 23.28 C Unresolved disorder model. using A ATOM 420 CG BGLN 50 -27.508 11.594 10.085 0.50 23.73 C Unresolved disorder model. using A ATOM 421 CD AGLN 50 -28.160 11.728 9.168 0.50 24.92 C Unresolved disorder model. using A ATOM 422 CD BGLN 50 -27.566 13.098 10.323 0.50 25.13 C Unresolved disorder model. using A ATOM 423 OE1AGLN 50 -27.674 12.441 8.289 0.50 30.74 O Unresolved disorder model. using A ATOM 424 OE1BGLN 50 -26.806 13.569 11.175 0.50 32.82 O Unresolved disorder model. using A ATOM 425 NE2AGLN 50 -29.302 11.088 8.984 0.50 26.76 N Unresolved disorder model. using A ATOM 426 NE2BGLN 50 -28.397 13.764 9.566 0.50 31.49 N Unresolved disorder model. using A ATOM 657 CA AASP 82 -17.163 12.115 28.940 0.50 15.88 C Unresolved disorder model. using A ATOM 658 CA BASP 82 -17.075 12.134 28.945 0.50 16.04 C Unresolved disorder model. using A ATOM 661 CB AASP 82 -16.335 12.802 30.021 0.50 20.34 C Unresolved disorder model. using A ATOM 662 CB BASP 82 -16.056 12.746 29.905 0.50 20.56 C Unresolved disorder model. using A ATOM 663 CG AASP 82 -16.673 12.213 31.390 0.50 22.29 C Unresolved disorder model. using A ATOM 664 CG BASP 82 -15.863 11.845 31.123 0.50 23.32 C Unresolved disorder model. using A ATOM 665 OD1AASP 82 -17.739 11.569 31.535 0.50 28.89 O Unresolved disorder model. using A ATOM 666 OD1BASP 82 -16.422 10.723 31.159 0.50 30.98 O Unresolved disorder model. using A ATOM 667 OD2AASP 82 -15.865 12.394 32.329 0.50 29.14 O Unresolved disorder model. using A ATOM 668 OD2BASP 82 -15.136 12.264 32.055 0.50 31.70 O Unresolved disorder model. using A ATOM 834 CA AGLU 103 -5.504 -8.377 19.599 0.50 6.64 C Unresolved disorder model. using A ATOM 835 CA BGLU 103 -5.571 -8.277 19.579 0.50 6.60 C Unresolved disorder model. using A ATOM 838 CB AGLU 103 -5.437 -6.918 19.154 0.50 7.15 C Unresolved disorder model. using A ATOM 839 CB BGLU 103 -5.694 -6.797 19.227 0.50 7.52 C Unresolved disorder model. using A ATOM 840 CG AGLU 103 -5.014 -6.880 17.682 0.50 7.22 C Unresolved disorder model. using A ATOM 841 CG BGLU 103 -5.390 -6.338 17.797 0.50 7.21 C Unresolved disorder model. using A ATOM 842 CD AGLU 103 -4.311 -5.570 17.398 0.50 4.96 C Unresolved disorder model. using A ATOM 843 CD BGLU 103 -3.905 -6.133 17.625 0.50 7.62 C Unresolved disorder model. using A ATOM 844 OE1AGLU 103 -4.916 -4.524 17.651 0.50 4.87 O Unresolved disorder model. using A ATOM 845 OE1BGLU 103 -3.142 -6.778 18.415 0.50 10.46 O Unresolved disorder model. using A ATOM 846 OE2AGLU 103 -3.183 -5.600 16.861 0.50 7.06 O Unresolved disorder model. using A ATOM 847 OE2BGLU 103 -3.420 -5.415 16.741 0.50 9.06 O Unresolved disorder model. using A ATOM 899 CA ALYS 110 -7.933 -15.579 20.662 0.50 8.59 C Unresolved disorder model. using A ATOM 900 CA BLYS 110 -7.928 -15.587 20.657 0.50 8.64 C Unresolved disorder model. using A ATOM 903 CB ALYS 110 -6.634 -15.948 19.957 0.50 9.40 C Unresolved disorder model. using A ATOM 904 CB BLYS 110 -6.613 -15.972 19.981 0.50 9.48 C Unresolved disorder model. using A ATOM 905 CG ALYS 110 -5.351 -15.658 20.747 0.50 10.56 C Unresolved disorder model. using A ATOM 906 CG BLYS 110 -5.376 -15.673 20.833 0.50 10.76 C Unresolved disorder model. using A ATOM 907 CD ALYS 110 -4.181 -16.331 20.035 0.50 11.96 C Unresolved disorder model. using A ATOM 908 CD BLYS 110 -4.099 -16.160 20.168 0.50 12.09 C Unresolved disorder model. using A ATOM 909 CE ALYS 110 -2.842 -15.884 20.581 0.50 13.14 C Unresolved disorder model. using A ATOM 910 CE BLYS 110 -2.892 -15.485 20.808 0.50 13.97 C Unresolved disorder model. using A ATOM 911 NZ ALYS 110 -2.579 -16.481 21.915 0.50 15.23 N Unresolved disorder model. using A ATOM 912 NZ BLYS 110 -1.788 -16.450 21.058 0.50 18.40 N Unresolved disorder model. using A ATOM 1042 CA AASP 126 -9.214 17.121 15.211 0.50 10.53 C Unresolved disorder model. using A ATOM 1043 CA BASP 126 -9.136 17.162 15.196 0.50 10.93 C Unresolved disorder model. using A ATOM 1046 CB AASP 126 -8.492 17.768 14.041 0.50 12.37 C Unresolved disorder model. using A ATOM 1047 CB BASP 126 -8.287 17.842 14.126 0.50 12.53 C Unresolved disorder model. using A ATOM 1048 CG AASP 126 -7.063 18.174 14.265 0.50 12.68 C Unresolved disorder model. using A ATOM 1049 CG BASP 126 -6.912 18.312 14.486 0.50 12.95 C Unresolved disorder model. using A ATOM 1050 OD1AASP 126 -6.421 17.766 15.237 0.50 17.66 O Unresolved disorder model. using A ATOM 1051 OD1BASP 126 -6.024 17.508 14.798 0.50 14.58 O Unresolved disorder model. using A ATOM 1052 OD2AASP 126 -6.572 18.946 13.406 0.50 19.32 O Unresolved disorder model. using A ATOM 1053 OD2BASP 126 -6.598 19.529 14.440 0.50 16.06 O Unresolved disorder model. using A ATOM 1070 CA ALYS 129 -4.509 16.787 18.331 0.25 10.08 C Unresolved disorder model. using A ATOM 1071 CA BLYS 129 -4.534 16.798 18.330 0.25 10.11 C Unresolved disorder model. using A ATOM 1072 CA CLYS 129 -4.525 16.779 18.335 0.50 10.10 C Unresolved disorder model. using A ATOM 1075 CB ALYS 129 -5.249 18.125 18.420 0.25 10.78 C Unresolved disorder model. using A ATOM 1076 CB BLYS 129 -5.306 18.120 18.321 0.25 11.05 C Unresolved disorder model. using A ATOM 1077 CB CLYS 129 -5.381 18.032 18.526 0.50 11.43 C Unresolved disorder model. using A ATOM 1078 CG ALYS 129 -5.168 18.735 19.812 0.25 10.06 C Unresolved disorder model. using A ATOM 1079 CG BLYS 129 -4.525 19.267 17.706 0.25 12.99 C Unresolved disorder model. using A ATOM 1080 CG CLYS 129 -4.954 19.137 17.638 0.50 13.82 C Unresolved disorder model. using A ATOM 1081 CD ALYS 129 -3.791 19.276 20.104 0.25 12.62 C Unresolved disorder model. using A ATOM 1082 CD BLYS 129 -3.414 19.847 18.551 0.25 14.73 C Unresolved disorder model. using A ATOM 1083 CD CLYS 129 -3.498 19.524 17.740 0.50 16.16 C Unresolved disorder model. using A ATOM 1084 CE ALYS 129 -3.819 20.117 21.375 0.25 14.92 C Unresolved disorder model. using A ATOM 1085 CE BLYS 129 -3.752 19.914 20.024 0.25 16.46 C Unresolved disorder model. using A ATOM 1086 CE CLYS 129 -3.185 20.603 16.729 0.50 17.24 C Unresolved disorder model. using A ATOM 1087 NZ ALYS 129 -4.543 21.399 21.232 0.25 15.21 N Unresolved disorder model. using A ATOM 1088 NZ BLYS 129 -3.335 18.642 20.691 0.25 17.46 N Unresolved disorder model. using A ATOM 1089 NZ CLYS 129 -4.217 20.746 15.654 0.50 16.68 N Unresolved disorder model. using A ATOM 1121 CA APRO 134 -4.743 10.604 27.366 0.50 9.74 C Unresolved disorder model. using A ATOM 1122 CA BPRO 134 -4.754 10.598 27.359 0.50 9.82 C Unresolved disorder model. using A ATOM 1125 CB APRO 134 -4.396 10.858 28.838 0.50 11.41 C Unresolved disorder model. using A ATOM 1126 CB BPRO 134 -4.459 10.788 28.856 0.50 11.53 C Unresolved disorder model. using A ATOM 1127 CG APRO 134 -4.576 12.330 29.010 0.50 10.93 C Unresolved disorder model. using A ATOM 1128 CG BPRO 134 -3.438 11.870 28.857 0.50 12.11 C Unresolved disorder model. using A ATOM 1129 CD APRO 134 -4.060 12.953 27.720 0.50 10.81 C Unresolved disorder model. using A ATOM 1130 CD BPRO 134 -3.942 12.836 27.802 0.50 10.89 C Unresolved disorder model. using A ATOM 1223 CA ASER 148 -22.406 -17.792 9.799 0.55 14.91 C Unresolved disorder model. using A ATOM 1224 CA BSER 148 -22.382 -17.829 9.743 0.15 14.99 C Unresolved disorder model. using A ATOM 1225 CA CSER 148 -22.378 -17.832 9.741 0.30 14.82 C Unresolved disorder model. using A ATOM 1228 CB ASER 148 -23.752 -17.533 10.479 0.55 16.23 C Unresolved disorder model. using A ATOM 1229 CB BSER 148 -23.796 -17.695 10.301 0.15 15.76 C Unresolved disorder model. using A ATOM 1230 CB CSER 148 -23.795 -17.681 10.284 0.30 15.78 C Unresolved disorder model. using A ATOM 1231 OG ASER 148 -24.239 -18.732 11.057 0.55 21.87 O Unresolved disorder model. using A ATOM 1232 OG BSER 148 -24.537 -16.683 9.650 0.15 16.82 O Unresolved disorder model. using A ATOM 1233 OG CSER 148 -23.823 -16.779 11.380 0.30 15.19 O Unresolved disorder model. using A ATOM 1361 CA ALYS 166 -0.140 -1.120 -0.154 0.50 9.47 C Unresolved disorder model. using A ATOM 1362 CA BLYS 166 -0.159 -1.117 -0.146 0.50 9.36 C Unresolved disorder model. using A ATOM 1365 CB ALYS 166 1.275 -1.245 0.452 0.50 11.10 C Unresolved disorder model. using A ATOM 1366 CB BLYS 166 1.234 -1.246 0.500 0.50 10.77 C Unresolved disorder model. using A ATOM 1367 CG ALYS 166 1.708 -0.108 1.334 0.50 13.57 C Unresolved disorder model. using A ATOM 1368 CG BLYS 166 1.660 -0.134 1.419 0.50 13.31 C Unresolved disorder model. using A ATOM 1369 CD ALYS 166 3.091 -0.203 1.926 0.50 17.06 C Unresolved disorder model. using A ATOM 1370 CD BLYS 166 2.959 -0.373 2.159 0.50 16.65 C Unresolved disorder model. using A ATOM 1371 CE ALYS 166 4.102 -0.894 1.034 0.50 18.32 C Unresolved disorder model. using A ATOM 1372 CE BLYS 166 3.535 0.894 2.753 0.50 18.73 C Unresolved disorder model. using A ATOM 1373 NZ ALYS 166 4.454 -0.117 -0.169 0.50 23.20 N Unresolved disorder model. using A ATOM 1374 NZ BLYS 166 2.769 1.470 3.885 0.50 24.88 N Unresolved disorder model. using A ATOM 1380 CA ALYS 168 -4.212 1.445 -3.137 0.50 10.67 C Unresolved disorder model. using A ATOM 1381 CA BLYS 168 -4.207 1.477 -3.151 0.50 10.67 C Unresolved disorder model. using A ATOM 1384 CB ALYS 168 -4.518 0.075 -3.752 0.50 11.88 C Unresolved disorder model. using A ATOM 1385 CB BLYS 168 -4.455 0.140 -3.853 0.50 11.38 C Unresolved disorder model. using A ATOM 1386 CG ALYS 168 -3.528 -0.359 -4.818 0.50 14.18 C Unresolved disorder model. using A ATOM 1387 CG BLYS 168 -3.445 -0.210 -4.933 0.50 13.74 C Unresolved disorder model. using A ATOM 1388 CD ALYS 168 -3.380 0.756 -5.848 0.50 18.69 C Unresolved disorder model. using A ATOM 1389 CD BLYS 168 -3.924 -1.303 -5.856 0.50 15.24 C Unresolved disorder model. using A ATOM 1390 CE ALYS 168 -2.861 0.208 -7.168 0.50 21.99 C Unresolved disorder model. using A ATOM 1391 CE BLYS 168 -3.049 -1.653 -7.027 0.50 19.41 C Unresolved disorder model. using A ATOM 1392 NZ ALYS 168 -2.357 1.222 -8.123 0.50 26.96 N Unresolved disorder model. using A ATOM 1393 NZ BLYS 168 -2.178 -0.594 -7.597 0.50 26.36 N Unresolved disorder model. using A ATOM 1406 CA AASP 171 -14.315 4.846 -3.362 0.50 12.39 C Unresolved disorder model. using A ATOM 1407 CA BASP 171 -14.298 4.878 -3.327 0.50 12.21 C Unresolved disorder model. using A ATOM 1410 CB AASP 171 -15.309 5.260 -4.455 0.50 14.13 C Unresolved disorder model. using A ATOM 1411 CB BASP 171 -15.151 5.474 -4.446 0.50 15.04 C Unresolved disorder model. using A ATOM 1412 CG AASP 171 -16.508 5.966 -3.850 0.50 14.19 C Unresolved disorder model. using A ATOM 1413 CG BASP 171 -14.628 6.757 -5.056 0.50 19.96 C Unresolved disorder model. using A ATOM 1414 OD1AASP 171 -16.374 7.202 -3.696 0.50 15.77 O Unresolved disorder model. using A ATOM 1415 OD1BASP 171 -14.234 7.685 -4.312 0.50 29.02 O Unresolved disorder model. using A ATOM 1416 OD2AASP 171 -17.552 5.340 -3.516 0.50 12.76 O Unresolved disorder model. using A ATOM 1417 OD2BASP 171 -14.639 6.924 -6.311 0.50 29.47 O Unresolved disorder model. using A ATOM 1509 CA AGLU 183 -26.934 -7.474 19.278 0.50 10.68 C Unresolved disorder model. using A ATOM 1510 CA BGLU 183 -26.939 -7.491 19.290 0.50 10.82 C Unresolved disorder model. using A ATOM 1513 CB AGLU 183 -27.807 -8.695 19.628 0.50 13.17 C Unresolved disorder model. using A ATOM 1514 CB BGLU 183 -27.740 -8.767 19.579 0.50 13.49 C Unresolved disorder model. using A ATOM 1515 CG AGLU 183 -28.593 -9.267 18.472 0.50 15.16 C Unresolved disorder model. using A ATOM 1516 CG BGLU 183 -28.962 -8.689 20.456 0.50 16.28 C Unresolved disorder model. using A ATOM 1517 CD AGLU 183 -29.241 -10.608 18.748 0.50 16.92 C Unresolved disorder model. using A ATOM 1518 CD BGLU 183 -29.576 -10.041 20.753 0.50 19.04 C Unresolved disorder model. using A ATOM 1519 OE1AGLU 183 -29.266 -11.019 19.926 0.50 20.60 O Unresolved disorder model. using A ATOM 1520 OE1BGLU 183 -29.335 -10.974 19.953 0.50 22.46 O Unresolved disorder model. using A ATOM 1521 OE2AGLU 183 -29.720 -11.260 17.788 0.50 25.67 O Unresolved disorder model. using A ATOM 1522 OE2BGLU 183 -30.291 -10.197 21.764 0.50 25.80 O Unresolved disorder model. using A ATOM 1644 CA ALEU 199 1.537 3.067 20.070 0.50 7.61 C Unresolved disorder model. using A ATOM 1645 CA BLEU 199 1.603 3.076 20.090 0.50 7.38 C Unresolved disorder model. using A ATOM 1648 CB ALEU 199 2.679 2.136 20.498 0.50 6.43 C Unresolved disorder model. using A ATOM 1649 CB BLEU 199 2.810 2.337 20.631 0.50 8.83 C Unresolved disorder model. using A ATOM 1650 CG ALEU 199 3.070 0.996 19.591 0.50 3.51 C Unresolved disorder model. using A ATOM 1651 CG BLEU 199 3.079 0.867 20.397 0.50 12.04 C Unresolved disorder model. using A ATOM 1652 CD1ALEU 199 4.392 0.327 19.939 0.50 6.86 C Unresolved disorder model. using A ATOM 1653 CD1BLEU 199 2.184 0.236 19.390 0.50 14.72 C Unresolved disorder model. using A ATOM 1654 CD2ALEU 199 1.991 -0.092 19.671 0.50 5.44 C Unresolved disorder model. using A ATOM 1655 CD2BLEU 199 4.531 0.601 19.997 0.50 14.18 C Unresolved disorder model. using A ATOM 1731 CA ALYS 209 -18.361 -9.044 25.025 0.50 10.08 C Unresolved disorder model. using A ATOM 1732 CA BLYS 209 -18.366 -9.043 25.026 0.50 10.15 C Unresolved disorder model. using A ATOM 1735 CB ALYS 209 -19.249 -9.232 26.264 0.50 13.90 C Unresolved disorder model. using A ATOM 1736 CB BLYS 209 -19.267 -9.249 26.255 0.50 13.92 C Unresolved disorder model. using A ATOM 1737 CG ALYS 209 -19.479 -10.683 26.607 0.50 18.00 C Unresolved disorder model. using A ATOM 1738 CG BLYS 209 -19.282 -10.690 26.716 0.50 17.81 C Unresolved disorder model. using A ATOM 1739 CD ALYS 209 -19.553 -11.000 28.080 0.50 20.63 C Unresolved disorder model. using A ATOM 1740 CD BLYS 209 -19.981 -10.938 28.028 0.50 21.01 C Unresolved disorder model. using A ATOM 1741 CE ALYS 209 -20.220 -12.355 28.331 0.50 22.47 C Unresolved disorder model. using A ATOM 1742 CE BLYS 209 -21.444 -10.553 28.033 0.50 24.11 C Unresolved disorder model. using A ATOM 1743 NZ ALYS 209 -20.631 -12.507 29.749 0.50 28.34 N Unresolved disorder model. using A ATOM 1744 NZ BLYS 209 -22.190 -11.031 29.231 0.50 30.34 N Unresolved disorder model. using A ATOM 1789 CA ASER 216 -14.928 -18.669 6.418 0.50 14.97 C Unresolved disorder model. using A ATOM 1790 CA BSER 216 -14.940 -18.693 6.402 0.50 15.28 C Unresolved disorder model. using A ATOM 1793 CB ASER 216 -14.814 -20.194 6.266 0.50 16.61 C Unresolved disorder model. using A ATOM 1794 CB BSER 216 -14.903 -20.219 6.232 0.50 17.18 C Unresolved disorder model. using A ATOM 1795 OG ASER 216 -13.443 -20.541 6.093 0.50 18.91 O Unresolved disorder model. using A ATOM 1796 OG BSER 216 -15.914 -20.674 5.353 0.50 21.43 O Unresolved disorder model. using A ATOM 1816 CA AVAL 219 -12.247 -13.966 6.383 0.50 12.29 C Unresolved disorder model. using A ATOM 1817 CA BVAL 219 -12.250 -14.018 6.406 0.50 12.66 C Unresolved disorder model. using A ATOM 1820 CB AVAL 219 -11.917 -14.575 7.751 0.50 13.77 C Unresolved disorder model. using A ATOM 1821 CB BVAL 219 -12.011 -14.760 7.721 0.50 13.40 C Unresolved disorder model. using A ATOM 1822 CG1AVAL 219 -12.753 -13.912 8.834 0.50 17.44 C Unresolved disorder model. using A ATOM 1823 CG1BVAL 219 -10.860 -14.080 8.487 0.50 13.05 C Unresolved disorder model. using A ATOM 1824 CG2AVAL 219 -12.054 -16.091 7.790 0.50 14.07 C Unresolved disorder model. using A ATOM 1825 CG2BVAL 219 -13.198 -14.821 8.648 0.50 17.20 C Unresolved disorder model. using A ATOM 1952 CA AGLU 235 3.633 -11.077 1.183 0.50 11.40 C Unresolved disorder model. using A ATOM 1953 CA BGLU 235 3.623 -11.111 1.174 0.50 11.57 C Unresolved disorder model. using A ATOM 1956 CB AGLU 235 4.551 -10.351 2.162 0.50 14.01 C Unresolved disorder model. using A ATOM 1957 CB BGLU 235 4.657 -10.435 2.063 0.50 13.50 C Unresolved disorder model. using A ATOM 1958 CG AGLU 235 4.700 -11.073 3.494 0.50 14.60 C Unresolved disorder model. using A ATOM 1959 CG BGLU 235 6.090 -10.674 1.638 0.50 13.47 C Unresolved disorder model. using A ATOM 1960 CD AGLU 235 5.162 -12.510 3.487 0.50 17.77 C Unresolved disorder model. using A ATOM 1961 CD BGLU 235 6.649 -12.077 1.645 0.50 17.04 C Unresolved disorder model. using A ATOM 1962 OE1AGLU 235 5.647 -13.057 2.486 0.50 22.04 O Unresolved disorder model. using A ATOM 1963 OE1BGLU 235 6.199 -12.928 2.446 0.50 19.89 O Unresolved disorder model. using A ATOM 1964 OE2AGLU 235 5.019 -13.155 4.561 0.50 21.93 O Unresolved disorder model. using A ATOM 1965 OE2BGLU 235 7.575 -12.425 0.855 0.50 21.93 O 1